Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Contrast Media/Contrast Agent Market: By Type: Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media, Others; By Modality; By Indication; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Contrast Media/Contrast Agent Market Outlook
The global contrast media/contrast agent market stood at a value of around USD 4.7 billion in 2020. The market is further expected to grow at a CAGR of 3.9% in the forecast period of 2022-2027 to attain a value of USD 6 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Heightened Usage of Iodinated Contrast Media to Aid the Global Contrast Media/Contrast Agent Industry Growth
Based on type, the iodinated contrast media segment is predicted to hold a significant market share in the contrast media/contrast agent industry. This growth can be attributed to the increased implementation of iodinated contrast media in X-ray and computer tomography (CT) scans. It is also used in fluoroscopy and venography.
In addition, the iodinated contrast agents, based on iodine, which is a naturally occurring element, are incredibly effective in image contrasting. Meanwhile, the barium-based contrast media are commonly taken orally and are available in powder, liquid, tablet, and paste forms. These factors are estimated to aid the overall market growth in the forecast period.
North America to Account for a Significant Market Share in the Global Contrast Media/Contrast Agent Industry
North America is estimated to hold a significant share of the contrast media/contrast agent industry in the forecast period. This increase can be attributed to the presence of the leading market players in the region. In addition, the rapid investments in the healthcare industry, along with the availability of state-of-the-art healthcare infrastructure, are also aiding the market growth. The growing availability of advanced diagnostic tools and the increased demand for diagnostic scanning and imaging technology are also predicted to bolster the industry growth. Furthermore, the rising incidences of chronic diseases are anticipated to provide a further boost to the overall market growth in the forecast period.
Contrast Media/Contrast Agent: Market Segmentation
Contrast media or contrast agents are materials used to enhance images of the inside of the body produced by X-Rays and MRI scans, among others. These substances help to create a contrast of solid structure and fluids present in the body. These materials are also crucial in determining normal and abnormal conditions in the image. In addition, these substances can be ingested, administered by enema, and injected into the blood vessels. In some situations, contrast agent makes the appearance of specific tissues in the body different, thus, helping to contrast between different spaces by accentuating certain areas of the body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the market is divided into:
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Microbubble Contrast Media
- Barium-Based Contrast Media
On the basis of modality, the market can be segmented into:
- X-Ray/CT
- Magnetic Resonance Imaging
- Ultrasound
Based on indication, the industry can be distributed into:
- Cardiovascular Disorders
- Cancer
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Others
Based on end use, the market can be categorised into:
- Hospitals, Clinics, and Ambulatory Surgery Centres
- Diagnostic Imaging Centres
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rise in Demand for Image-Based Diagnostics to Augment the Global Contrast Media/Contrast Agent Industry
The increasing incidences of chronic diseases are anticipated to drive the contrast media/contrast agent industry growth in the coming years. According to the WHO statistics, approximately 10 million people succumbed to cancer in 2020, out of which the most common types include breast, lungs, colon and rectum, and prostate cancer. In this regard, image-guided diagnostic procedures are increasingly being used to help determine the location, size, and condition of the tumour, whether it is malignant or benign, thus, making efforts to reduce the mortality risk associated with cancer. Moreover, the growing geriatric population, with increased susceptibility to chronic diseases, is also anticipated to propel the demand for contrast media. Furthermore, the rising investments in the research and development of image-based diagnosis technologies to enhance their precision, processing, and applications are anticipated to aid the industry growth. These factors are estimated to positively impact the market growth in the forecast period.
Key Industry Players in the Global Contrast Media/Contrast Agent Market
The report gives a detailed analysis of the following key players in the global contrast media/contrast agent market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- GE Healthcare
- Bracco Imaging S.P.A
- Bayer AG
- Guerbet
- Nano Therapeutics Pvt. Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Modality, Indication, End Use, Region |
| Breakup by Type | Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media, Barium-Based Contrast Media |
| Breakup by Modality | X-Ray/CT, Magnetic Resonance Imaging, Ultrasound |
| Breakup by Indication | Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Others |
| Breakup by End Use | Hospitals, Clinics, and Ambulatory Surgery Centres, Diagnostic Imaging Centres |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | GE Healthcare, Bracco Imaging S.P.A, Bayer AG, Guerbet, Nano Therapeutics Pvt. Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Contrast Media/Contrast Agent Market Analysis
8.1 Key Industry Highlights
8.2 Global Contrast Media/Contrast Agent Historical Market (2017-2021)
8.3 Global Contrast Media/Contrast Agent Market Forecast (2022-2027)
8.4 Global Contrast Media/Contrast Agent Market by Type
8.4.1 Iodinated Contrast Media
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Gadolinium-Based Contrast Media
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Microbubble Contrast Media
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Barium-Based Contrast Media
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.5 Global Contrast Media/Contrast Agent Market by Modality
8.5.1 X-Ray/CT
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Magnetic Resonance Imaging
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Ultrasound
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.6 Global Contrast Media/Contrast Agent Market by Indication
8.6.1 Cardiovascular Disorders
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Cancer
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Gastrointestinal Disorders
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Musculoskeletal Disorders
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Neurological Disorders
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2017-2021)
8.6.5.3 Forecast Trend (2022-2027)
8.6.6 Others
8.7 Global Contrast Media/Contrast Agent Market by End Use
8.7.1 Hospitals, Clinics, and Ambulatory Surgery Centres
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Diagnostic Imaging Centres
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.8 Global Contrast Media/Contrast Agent Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 GE Healthcare
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Bracco Imaging S.P.A
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Bayer AG
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Guerbet
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Nano Therapeutics Pvt. Ltd.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Contrast Media/Contrast Agent Market: Key Industry Highlights, 2016 and 2026
2. Global Contrast Media/Contrast Agent Historical Market: Breakup by Type (USD Billion), 2017-2021
3. Global Contrast Media/Contrast Agent Market Forecast: Breakup by Type (USD Billion), 2022-2027
4. Global Contrast Media/Contrast Agent Historical Market: Breakup by Modality (USD Billion), 2017-2021
5. Global Contrast Media/Contrast Agent Market Forecast: Breakup by Modality (USD Billion), 2022-2027
6. Global Contrast Media/Contrast Agent Historical Market: Breakup by Indication (USD Billion), 2017-2021
7. Global Contrast Media/Contrast Agent Market Forecast: Breakup by Indication (USD Billion), 2022-2027
8. Global Contrast Media/Contrast Agent Historical Market: Breakup by End Use (USD Billion), 2017-2021
9. Global Contrast Media/Contrast Agent Market Forecast: Breakup by End Use (USD Billion), 2022-2027
10. Global Contrast Media/Contrast Agent Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Contrast Media/Contrast Agent Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Contrast Media/Contrast Agent Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Contrast Media/Contrast Agent Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Contrast Media/Contrast Agent Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Contrast Media/Contrast Agent Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Contrast Media/Contrast Agent Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Contrast Media/Contrast Agent Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Contrast Media/Contrast Agent Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Contrast Media/Contrast Agent Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Contrast Media/Contrast Agent Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Contrast Media/Contrast Agent Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Contrast Media/Contrast Agent Market Structure
Key Questions Answered in the Report
In 2020, the global contrast media/contrast agent market attained a value of nearly USD 4.7 billion.
The market is projected to grow at a CAGR of 3.9% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 6 billion by 2026.
The major drivers of the industry, such as the increased demand for advanced diagnostic procedures, increasing incidences of chronic disorders, rising geriatric population, and increasing investments in research and development of contrast agents by the leading manufacturers, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing availability of improved diagnostic facilities and the rise in demand for image-guided diagnostic procedures.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product types include iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media.
The significant segments, based on modality, include X-ray/CT, magnetic resonance imaging, and ultrasound.
The major segments, based on indication, include cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and others.
The significant end uses include hospitals, clinics and ambulatory surgery centres, and diagnostic imaging centres.
The major players in the industry are GE Healthcare, Bracco Imaging S.P.A, Bayer AG, Guerbet, and Nano Therapeutics Pvt. Ltd., among others.
Analyst Review
The global contrast media/contrast agent market attained a value of USD 4.7 billion in 2020, driven by the increased incidences of chronic disorders. Aided by the rising demand for image-guided diagnostics, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 3.9%. The market is projected to reach USD 6 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of type, the market can be distributed into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media and barium-based contrast media. By modality, the industry can be segmented into X-ray/CT, magnetic resonance imaging, and ultrasound. Based on indication, the market can be categorised into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and others. On the basis of end use, the industry can be segregated into hospitals, clinics and ambulatory surgery centres, and diagnostic imaging centres. The major regional markets for contrast media/contrast agent are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include GE Healthcare, Bracco Imaging S.P.A, Bayer AG, Guerbet, Nano Therapeutics Pvt. Ltd., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global humanised mouse and rat model market attained a value of more than USD 105.9 million in 2021, driven by the growing demand for personalised medicine. Aided by the increasing number of resea...
The global hospital curtains market is being driven by the growing need to replace hospital curtains at fixed intervals and the increasing focus to enhance patient care. Aided by the increasing inclin...
The global cell-based assays market reached a value of more than USD 6677 million in 2021, driven by the rising incidences of chronic illnesses, such as cancer and cardiovascular diseases. Aided by th...
The United States medical writing market attained a value of USD 0.9 billion in 2021, driven by the thriving healthcare and pharmaceutical industry in the country. Aided by the growing FDA approval of...
The global 3D printing in healthcare market attained a value of USD 1120.5 million in 2021, driven by the increased demand for 3D printing across the medical sector. Aided by heightened technological ...
NEWSLETTER